Epidermal growth factor receptor mutation predicts favorable outcomes in non-small cell lung cancer patients with brain metastases treated with stereotactic radiosurgery.

scientific article published on 27 October 2017

Epidermal growth factor receptor mutation predicts favorable outcomes in non-small cell lung cancer patients with brain metastases treated with stereotactic radiosurgery. is …
instance of (P31):
scholarly articleQ13442814

External links are
P356DOI10.1016/J.RADONC.2017.10.010
P698PubMed publication ID29111173

P50authorChong-Jen YuQ42255080
Wei-Yu LiaoQ57020031
Furen XiaoQ58049742
P2093author name stringJin-Yuan Shih
Kuan-Yu Chen
Pan-Chyr Yang
Ya-Fang Chen
Ham-Min Tseng
Sung-Hsin Kuo
James Chih-Hsin Yang
Jason Chia-Hsien Cheng
Chao-Chi Ho
Feng-Ming Hsu
Wen-Chi Yang
P433issue2
P921main subjectbrain metastasisQ1620196
P304page(s)368-374
P577publication date2017-10-27
P1433published inRadiotherapy and OncologyQ14251029
P1476titleEpidermal growth factor receptor mutation predicts favorable outcomes in non-small cell lung cancer patients with brain metastases treated with stereotactic radiosurgery
P478volume126

Reverse relations

cites work (P2860)
Q64092263Comparing the efficacy of concurrent EGFR-TKI and whole-brain radiotherapy vs EGFR-TKI alone as a first-line therapy for advanced -mutated non-small-cell lung cancer with brain metastases: a retrospective cohort study
Q92159112EGFR mutant locally advanced non-small cell lung cancer is at increased risk of brain metastasis
Q90437483The usefulness of stereotactic radiosurgery for recursive partitioning analysis class II/III lung cancer patients with brain metastases in the modern treatment era
Q64096454Upfront whole brain radiotherapy for multiple brain metastases in patients with EGFR-mutant lung adenocarcinoma
Q92166938[Prognostic Analysis of EGFR-TKIs Combined with Gamma Knife in EGFR-mutant Lung Adenocarcinoma with Brain Metastasis]

Search more.